Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0
Cardiovascular diseases (CVDs) continue to be the leading cause of mortality worldwide, with an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Heart attacks and strokes accounted for approximately 85% of these fatalities The prevalence of CVDs is worsened by metabolic...
Gardado en:
| Formato: | Online |
|---|---|
| Idioma: | inglés |
| Publicado: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Subjects: | |
| Acceso en liña: | ONIX_20240906_9783725816675_183 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
| _version_ | 1863733947242905600 |
|---|---|
| collection | Directory of Open Access Books |
| description | Cardiovascular diseases (CVDs) continue to be the leading cause of mortality worldwide, with an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Heart attacks and strokes accounted for approximately 85% of these fatalities The prevalence of CVDs is worsened by metabolic diseases, particularly diabetes, which affects about 422 million people globally, primarily in low- and middle-income countries, and causes 1.5 million deaths annually. Early detection and intervention of CVDs and metabolic diseases are crucial, as many cases can be prevented by addressing modifiable behavioral risk factors such as tobacco use, unhealthy diet, obesity, physical inactivity, and harmful alcohol consumption. Significant advancements in treatment, from pharmacological developments to both invasive and non-invasive techniques, are continuously being made. Given the complexity and clinical significance of this topic, Biomedicines is proud to present a Special Issue titled "Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0". This issue aims to compile contemporary scientific information on emerging treatments for CVDs and metabolic diseases. They provide valuable insights to the field and enhance our understanding of these interconnected health challenges. |
| format | Online |
| id | doab-20.500.12854ir-143821 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1438212024-09-06T08:32:35Z Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 Caturano, Alfredo calcification inflammation osteopontin carotid stenosis carotid endarterectomy thyroid hormone thyroid receptors low T3 syndrome heart failure coronary disease cardiac remodeling cardiovascular surgery patients aortic aneurism aortic dissection aromatic microbial metabolites tyrosine metabolites 4-hydroxyphenyllactic acid infectious complications atrial fibrillation electrical cardioversion post-procedural complications biomarkers fibroblast growth factor 23 two-dimensional speckle-tracking echocardiography left ventricular diastolic dysfunction diabetes mellitus lipoprotein(a) children adolescents cardiovascular risk cardiovascular disease diet herbs pharmaceutical drugs remodeling myocardial infarction cardiac macrophages kidney macrophages sodium/glucose cotransporter 2 (SGLT2) inhibitors bexagliflozin cardiovascular diseases conventional risk factors cardiovascular prevention emerging risk factors handgrip metabolic syndrome blood pressure isometric strength vascular stiffness muscle strength dynamometer treatment real-life sodium-glucose cotransporter-2 inhibitors glucagon-like peptide-1 receptor agonist orthotopic heart transplantation (OHT) transcatheter aortic valve implantation (TAVI) heart valve replacement aortic valve obesity hypoventilation syndrome obstructive sleep apnea CPAP noninvasive ventilation NIV adherence cognitive training multi-tasking postoperative cognitive dysfunction cardiac surgery fatty liver index orthotopic liver transplantation stroke PCSK9 PCSK9 inhibitor evolocumab women’s health cardiovascular echocardiography sleep apnea adenotonsillectomy exosomal RNA sequencing exosome acute myocardial infarction microRNA cardiac tissue platelet proteomics CVDs cancer transfusion n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Cardiovascular diseases (CVDs) continue to be the leading cause of mortality worldwide, with an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Heart attacks and strokes accounted for approximately 85% of these fatalities The prevalence of CVDs is worsened by metabolic diseases, particularly diabetes, which affects about 422 million people globally, primarily in low- and middle-income countries, and causes 1.5 million deaths annually. Early detection and intervention of CVDs and metabolic diseases are crucial, as many cases can be prevented by addressing modifiable behavioral risk factors such as tobacco use, unhealthy diet, obesity, physical inactivity, and harmful alcohol consumption. Significant advancements in treatment, from pharmacological developments to both invasive and non-invasive techniques, are continuously being made. Given the complexity and clinical significance of this topic, Biomedicines is proud to present a Special Issue titled "Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0". This issue aims to compile contemporary scientific information on emerging treatments for CVDs and metabolic diseases. They provide valuable insights to the field and enhance our understanding of these interconnected health challenges. 2024-09-06T08:32:26Z 2024-09-06T08:32:26Z 2024 book ONIX_20240906_9783725816675_183 9783725816675 9783725816682 https://directory.doabooks.org/handle/20.500.12854/143821 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9573 https://mdpi.com/books/pdfview/book/9573 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-1668-2 10.3390/books978-3-7258-1668-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725816675 9783725816682 open access |
| spellingShingle | calcification inflammation osteopontin carotid stenosis carotid endarterectomy thyroid hormone thyroid receptors low T3 syndrome heart failure coronary disease cardiac remodeling cardiovascular surgery patients aortic aneurism aortic dissection aromatic microbial metabolites tyrosine metabolites 4-hydroxyphenyllactic acid infectious complications atrial fibrillation electrical cardioversion post-procedural complications biomarkers fibroblast growth factor 23 two-dimensional speckle-tracking echocardiography left ventricular diastolic dysfunction diabetes mellitus lipoprotein(a) children adolescents cardiovascular risk cardiovascular disease diet herbs pharmaceutical drugs remodeling myocardial infarction cardiac macrophages kidney macrophages sodium/glucose cotransporter 2 (SGLT2) inhibitors bexagliflozin cardiovascular diseases conventional risk factors cardiovascular prevention emerging risk factors handgrip metabolic syndrome blood pressure isometric strength vascular stiffness muscle strength dynamometer treatment real-life sodium-glucose cotransporter-2 inhibitors glucagon-like peptide-1 receptor agonist orthotopic heart transplantation (OHT) transcatheter aortic valve implantation (TAVI) heart valve replacement aortic valve obesity hypoventilation syndrome obstructive sleep apnea CPAP noninvasive ventilation NIV adherence cognitive training multi-tasking postoperative cognitive dysfunction cardiac surgery fatty liver index orthotopic liver transplantation stroke PCSK9 PCSK9 inhibitor evolocumab women’s health cardiovascular echocardiography sleep apnea adenotonsillectomy exosomal RNA sequencing exosome acute myocardial infarction microRNA cardiac tissue platelet proteomics CVDs cancer transfusion n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
| title | Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
| title_full | Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
| title_fullStr | Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
| title_full_unstemmed | Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
| title_short | Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
| title_sort | cardiovascular and metabolic disease new treatment and future directions 2 0 |
| topic | calcification inflammation osteopontin carotid stenosis carotid endarterectomy thyroid hormone thyroid receptors low T3 syndrome heart failure coronary disease cardiac remodeling cardiovascular surgery patients aortic aneurism aortic dissection aromatic microbial metabolites tyrosine metabolites 4-hydroxyphenyllactic acid infectious complications atrial fibrillation electrical cardioversion post-procedural complications biomarkers fibroblast growth factor 23 two-dimensional speckle-tracking echocardiography left ventricular diastolic dysfunction diabetes mellitus lipoprotein(a) children adolescents cardiovascular risk cardiovascular disease diet herbs pharmaceutical drugs remodeling myocardial infarction cardiac macrophages kidney macrophages sodium/glucose cotransporter 2 (SGLT2) inhibitors bexagliflozin cardiovascular diseases conventional risk factors cardiovascular prevention emerging risk factors handgrip metabolic syndrome blood pressure isometric strength vascular stiffness muscle strength dynamometer treatment real-life sodium-glucose cotransporter-2 inhibitors glucagon-like peptide-1 receptor agonist orthotopic heart transplantation (OHT) transcatheter aortic valve implantation (TAVI) heart valve replacement aortic valve obesity hypoventilation syndrome obstructive sleep apnea CPAP noninvasive ventilation NIV adherence cognitive training multi-tasking postoperative cognitive dysfunction cardiac surgery fatty liver index orthotopic liver transplantation stroke PCSK9 PCSK9 inhibitor evolocumab women’s health cardiovascular echocardiography sleep apnea adenotonsillectomy exosomal RNA sequencing exosome acute myocardial infarction microRNA cardiac tissue platelet proteomics CVDs cancer transfusion n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | calcification inflammation osteopontin carotid stenosis carotid endarterectomy thyroid hormone thyroid receptors low T3 syndrome heart failure coronary disease cardiac remodeling cardiovascular surgery patients aortic aneurism aortic dissection aromatic microbial metabolites tyrosine metabolites 4-hydroxyphenyllactic acid infectious complications atrial fibrillation electrical cardioversion post-procedural complications biomarkers fibroblast growth factor 23 two-dimensional speckle-tracking echocardiography left ventricular diastolic dysfunction diabetes mellitus lipoprotein(a) children adolescents cardiovascular risk cardiovascular disease diet herbs pharmaceutical drugs remodeling myocardial infarction cardiac macrophages kidney macrophages sodium/glucose cotransporter 2 (SGLT2) inhibitors bexagliflozin cardiovascular diseases conventional risk factors cardiovascular prevention emerging risk factors handgrip metabolic syndrome blood pressure isometric strength vascular stiffness muscle strength dynamometer treatment real-life sodium-glucose cotransporter-2 inhibitors glucagon-like peptide-1 receptor agonist orthotopic heart transplantation (OHT) transcatheter aortic valve implantation (TAVI) heart valve replacement aortic valve obesity hypoventilation syndrome obstructive sleep apnea CPAP noninvasive ventilation NIV adherence cognitive training multi-tasking postoperative cognitive dysfunction cardiac surgery fatty liver index orthotopic liver transplantation stroke PCSK9 PCSK9 inhibitor evolocumab women’s health cardiovascular echocardiography sleep apnea adenotonsillectomy exosomal RNA sequencing exosome acute myocardial infarction microRNA cardiac tissue platelet proteomics CVDs cancer transfusion n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | ONIX_20240906_9783725816675_183 |